However, calreticulin can also be co-located in the nucleus, elevated levels being associated with additional cellular processes, and particularly with poor outcomes in some cancers as reviewed by Fucikova et al., in line with enhanced angiogenesis and facilitation of the migration and proliferation of tumor cells [53]. This evidence concerns the gene CALR and neoplasm.